About Us
Our mission is to empower people living with neuromuscular diseases to live longer, more independent lives.
Press Releases
-
May 5, 2025Muscular Dystrophy Association’s EVP and Chief Research Officer Sharon Hesterlee, PhD, appointed interim President and Chief Executive Officer.
-
Apr 30, 2025First and only FcRn blocker approved in anti-AChR and anti-MuSK antibody positive adults and pediatric gMG patients aged 12 and older.
-
Apr 29, 2025Building on its 75-year legacy of progress, MDA is reinforcing its commitment to the ALS community by driving momentum for treatments and expanding access to multidisciplinary care.
-
Apr 28, 2025MDA Ambassador Fred Graves, who lives with limb-girdle muscular dystrophy, will be honored at the event.
-
Apr 22, 2025
-
Apr 8, 2025Studies show a heightened prevalence of ALS among fire fighters, who are diagnosed at twice the rate of the general population. The MDA & IAFF are focused on finding the cause.
Press Releases
-
May 5, 2025Muscular Dystrophy Association’s EVP and Chief Research Officer Sharon Hesterlee, PhD, appointed interim President and Chief Executive Officer.
-
Apr 30, 2025First and only FcRn blocker approved in anti-AChR and anti-MuSK antibody positive adults and pediatric gMG patients aged 12 and older.
-
Apr 29, 2025Building on its 75-year legacy of progress, MDA is reinforcing its commitment to the ALS community by driving momentum for treatments and expanding access to multidisciplinary care.
-
Apr 28, 2025MDA Ambassador Fred Graves, who lives with limb-girdle muscular dystrophy, will be honored at the event.
-
Apr 22, 2025
-
Apr 8, 2025Studies show a heightened prevalence of ALS among fire fighters, who are diagnosed at twice the rate of the general population. The MDA & IAFF are focused on finding the cause.